Trust of Molina Healthcare (MOH) director Zoretic buys 800 shares

Rhea-AI Filing Summary

Molina Healthcare, Inc. director Richard C. Zoretic reported an indirect open-market purchase of company stock through a trust associated with him. On 02/11/2026, the Richard Charles Zoretic Revocable Living Trust bought 800 shares of Molina Healthcare common stock at $125.16 per share.

Following this transaction, the trust beneficially owns 8,747 shares of Molina Healthcare common stock, all reported as indirect ownership by Zoretic.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ZORETIC RICHARD C

(Last) (First) (Middle)

2180 HARVARD STREET

SUITE 400

(Street)

SACRAMENTO CA 95815

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/11/2026		P		800	A	$125.16	8,747	I	Held by trust(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. All shares held by the Richard Charles Zoretic Revocable Living Trust.

Remarks:

	Jeff D. Barlow, by power of attorney for Richard C. Zoretic	02/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Molina Healthcare (MOH) disclose for Richard C. Zoretic?

Molina Healthcare disclosed that a trust associated with director Richard C. Zoretic purchased 800 shares of common stock. The open-market transaction occurred on February 11, 2026, and was reported as an indirect holding on his Form 4 filing.

At what price were the Molina Healthcare (MOH) shares purchased in this Form 4 filing?

The trust associated with director Richard C. Zoretic bought the 800 Molina Healthcare common shares at $125.16 per share. This price reflects the purchase cost reported in the Form 4 insider trading disclosure filed with regulators.

How many Molina Healthcare (MOH) shares does the Zoretic trust hold after this transaction?

After the reported purchase, the Richard Charles Zoretic Revocable Living Trust beneficially owns 8,747 Molina Healthcare common shares. These shares are reported as indirect ownership for director Richard C. Zoretic under the Form 4 filing.

Is the Molina Healthcare (MOH) Form 4 transaction a direct or indirect holding for Richard C. Zoretic?

The transaction is reported as an indirect holding for Richard C. Zoretic. All 8,747 shares, including the newly purchased 800 shares, are held by the Richard Charles Zoretic Revocable Living Trust, as noted in the filing’s footnote.

What type of transaction is reported in the Molina Healthcare (MOH) Form 4 for Richard C. Zoretic?

The Form 4 reports an open-market purchase of common stock, coded “P” for purchase. A trust associated with director Richard C. Zoretic acquired 800 Molina Healthcare shares in this transaction on February 11, 2026.

Who executed the Molina Healthcare (MOH) share purchase reported for Richard C. Zoretic?

All reported shares are held by the Richard Charles Zoretic Revocable Living Trust. The Form 4 explains that the shares, including the newly bought 800 shares, are owned by this trust and reported as indirect ownership for director Richard C. Zoretic.